Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

234 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Polymorphic epithelial mucin (MUC-1)-containing circulating immune complexes in carcinoma patients.
Gourevitch MM, von Mensdorff-Pouilly S, Litvinov SV, Kenemans P, van Kamp GJ, Verstraeten AA, Hilgers J. Gourevitch MM, et al. Br J Cancer. 1995 Oct;72(4):934-8. doi: 10.1038/bjc.1995.436. Br J Cancer. 1995. PMID: 7547243 Free PMC article.
Antibody-dependent cell-mediated cytotoxicity can be induced by MUC1 peptide vaccination of breast cancer patients.
Snijdewint FG, von Mensdorff-Pouilly S, Karuntu-Wanamarta AH, Verstraeten AA, Livingston PO, Hilgers J, Kenemans P. Snijdewint FG, et al. Int J Cancer. 2001 Jul 1;93(1):97-106. doi: 10.1002/ijc.1286. Int J Cancer. 2001. PMID: 11391628
Reactivity of natural and induced human antibodies to MUC1 mucin with MUC1 peptides and n-acetylgalactosamine (GalNAc) peptides.
von Mensdorff-Pouilly S, Petrakou E, Kenemans P, van Uffelen K, Verstraeten AA, Snijdewint FG, van Kamp GJ, Schol DJ, Reis CA, Price MR, Livingston PO, Hilgers J. von Mensdorff-Pouilly S, et al. Int J Cancer. 2000 Jun 1;86(5):702-12. doi: 10.1002/(sici)1097-0215(20000601)86:5<702::aid-ijc16>3.0.co;2-1. Int J Cancer. 2000. PMID: 10797294
Isolation of MUC1-primed B lymphocytes from tumour-draining lymph nodes by immunomagnetic beads.
Petrarca C, Casalino B, von Mensdorff-Pouilly S, Rughetti A, Rahimi H, Scambia G, Hilgers J, Frati L, Nuti M. Petrarca C, et al. Cancer Immunol Immunother. 1999 Jan;47(5):272-7. doi: 10.1007/s002620050531. Cancer Immunol Immunother. 1999. PMID: 10022471
Cellular and humoral immune responses to MUC1 mucin and tandem-repeat peptides in ovarian cancer patients and controls.
Snijdewint FG, von Mensdorff-Pouilly S, Karuntu-Wanamarta AH, Verstraeten AA, van Zanten-Przybysz I, Hummel P, Nijman HW, Kenemans P, Hilgers J. Snijdewint FG, et al. Cancer Immunol Immunother. 1999 Apr;48(1):47-55. doi: 10.1007/s002620050547. Cancer Immunol Immunother. 1999. PMID: 10235488
Quantification of MUC1 in breast cancer patients. A method comparison study.
Bon GG, van Kamp GJ, Verstraeten RA, von Mensdorff-Pouilly S, Hilgers J, Kenemans P. Bon GG, et al. Eur J Obstet Gynecol Reprod Biol. 1999 Mar;83(1):67-75. doi: 10.1016/s0301-2115(98)00302-9. Eur J Obstet Gynecol Reprod Biol. 1999. PMID: 10221613
Autoantibodies to p53 in ovarian cancer patients and healthy women: a comparison between whole p53 protein and 18-mer peptides for screening purposes.
Vennegoor CJ, Nijman HW, Drijfhout JW, Vernie L, Verstraeten RA, von Mensdorff-Pouilly S, Hilgers J, Verheijen RH, Kast WM, Melief CJ, Kenemans P. Vennegoor CJ, et al. Cancer Lett. 1997 Jun 3;116(1):93-101. doi: 10.1016/s0304-3835(97)00168-7. Cancer Lett. 1997. PMID: 9177463
Clinical and technical evaluation of ACS BR serum assay of MUC1 gene-derived glycoprotein in breast cancer, and comparison with CA 15-3 assays.
Bon GG, von Mensdorff-Pouilly S, Kenemans P, van Kamp GJ, Verstraeten RA, Hilgers J, Meijer S, Vermorken JB. Bon GG, et al. Clin Chem. 1997 Apr;43(4):585-93. Clin Chem. 1997. PMID: 9105258
Evaluation of colorectal cancer-associated mucin CA M43 assay in serum.
van Kamp GJ, von Mensdorff-Pouilly S, Kenemans P, Verstraeten R, Yedema CA, Wobbes T, Bon GG, Kok A, Brown JP, Hilgers J, et al. van Kamp GJ, et al. Clin Chem. 1993 Jun;39(6):1029-32. Clin Chem. 1993. PMID: 8504532
CA 125 half-life in ovarian cancer: a multivariate survival analysis.
Yedema CA, Kenemans P, Voorhorst F, Bon G, Schijf C, Beex L, Verstraeten A, Hilgers J, Vermorken J. Yedema CA, et al. Br J Cancer. 1993 Jun;67(6):1361-7. doi: 10.1038/bjc.1993.252. Br J Cancer. 1993. PMID: 8512822 Free PMC article.
234 results
Jump to page
Feedback